Why is IRD Down Today?
About Opus Genetics, Inc. Common Stock
Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapie...
Overall Confidence: 60%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: -0.6%
Market Comparison
Quick Trade Ideas
Options strategies to consider for IRD's -5% move
No Options Available
IRD doesn't have listed options or options data is currently unavailable.
Try another stock in our Options Calculator →🔔 Get IRD Alerts
We'll notify you when IRD's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
IRD has moved more than 3.0% down on 61 occasions in the past year.
Frequently Asked Questions
Why is IRD stock down today?
This stock is significantly underperforming its PHARMACEUTICAL PREPARATIONS sector peers, suggesting a stock-specific catalyst.
Is IRD stock a buy or sell right now?
Based on current analysis, IRD shows 60% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the IRD stock price target?
IRD is currently trading at $4.09. Based on today's momentum, the expected short-term range is $3.96 - $4.17. See long-term price prediction →
Will IRD stock continue falling?
Our analysis shows a 45% probability that IRD's move continues in the next 1-3 days. Key level to watch: $3.88 (support).
Is IRD stock oversold or overbought?
IRD's RSI (Relative Strength Index) is currently at 49.0. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for IRD stock?
IRD's 10-day momentum indicator is at 0.41. Positive momentum - the stock has mild upward pressure supporting the current trend.
Is IRD outperforming or underperforming the market?
IRD (-5.22%) is currently significantly underperforming the market (-4.9% vs SPY). Today, the S&P 500 (SPY) is down -0.35%, and Nasdaq (QQQ) is down -0.32%.
What does MACD indicate for IRD?
IRD's MACD (-0.03) is currently above the signal line (-0.1), indicating a bullish trend. This technical signal suggests buying pressure is dominant. The trend strength (ADX: 12.7) is weak.
Is IRD in an uptrend or downtrend?
Based on moving average analysis, IRD is in a mixed/transitional trend. The price and moving averages are not clearly aligned, suggesting a potential trend change or consolidation phase. 20-day SMA: $3.89, 50-day SMA: $4.5.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis